Skip to content
GK24
Reports & IndicesEasy

What is India's treatment success rate among patients with drug-susceptible tuberculosis?

  1. A.84%
  2. B.88%
  3. C.91%
  4. D.94%

Correct answer

D. 94%

Explanation

The correct answer is 94%. For patients with drug-susceptible TB, India completes treatment successfully in 94% of cases, a figure the WHO Global Tuberculosis Report 2026 highlights alongside the fall in deaths. The report ties this outcome to prompt start of treatment, differentiated care for patients, nutritional help under the Ni-kshay Poshan Yojana and follow-up through the Ni-kshay digital platform. Options A, B and C are all lower than the recorded rate and none of them appears in the report; they are the kind of plausible near-misses a paper setter uses. One other percentage from the same release is worth keeping separate in memory: 96%, which is the share of the TB programme's funding requirement met from domestic resources. Do not confuse the treatment success rate of 94% with that financing figure.

Read the full article: WHO Global TB Report 2026: India's TB Deaths Down 38%

Q3.Reports & IndicesMedium

Which agency conducted the nationally representative TB prevalence survey of 2025 that has been shared with WHO?

  1. A.ICMR-NIRT
  2. B.Registrar General of India
  3. C.National Health Authority
  4. D.Central Bureau of Health Intelligence
Show answer
Correct answer: A. ICMR-NIRT

It carried out the nationally representative prevalence survey in 2025; the findings have gone to the World Health Organization, technical discussions are under way, and an updated country profile for India is to be published after that.

Q4.Reports & IndicesMedium

Which sector is described in the NITI Aayog report as an early implementation success under the PLI route?

  1. A.Drones
  2. B.Speciality steel
  3. C.Technical textiles
  4. D.Advanced Chemistry Cell batteries
Show answer
Correct answer: A. Drones

Among the sectors with strong industry participation, the report singles out the drones segment as the one that turned incentives into results earliest, alongside notable progress in pharmaceuticals, mobile phone manufacturing under Large Scale Electronics Manufacturing, food processing, telecom, white goods and automobiles.